Phospholipid binding improves plasma survival of factor VIII.
Pisal
Dipak S
DS
Balu-Iyer
Sathy V
SV
D000818:Animals; D019540:Area Under Curve; D003029:Coagulants / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004195:Disease Models, Animal; D005169:Factor VIII / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006207:Half-Life; D006467:Hemophilia A / Q000097:blood / Q000188:drug therapy*; D008657:Metabolic Clearance Rate; D051379:Mice; D018345:Mice, Knockout; D010716:Phosphatidylinositols / Q000008:administration & dosage / Q000493:pharmacokinetics; D010743:Phospholipids / Q000008:administration & dosage / Q000493:pharmacokinetics*; D014841:von Willebrand Factor / Q000235:genetics / Q000378:metabolism
D003029:Coagulants; D010716:Phosphatidylinositols; D010743:Phospholipids; D014841:von Willebrand Factor; D005169:Factor VIII